Clinical biochemistry of calcium and vitamin D

Similar documents
Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

Hyper and hypocalcaemia. Prof Tricia Tan

Definition Elevated Adjusted Calcium > 2.6 mmol/l (adjusted for albumin), taken without using a cuff.

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences

Parathyroid hormone (serum, plasma)

Guideline on Diagnosis & Management of Vitamin D Deficiency in Adults for Non-Specialists

Investigations for Disorders of Calcium, Phosphate and Magnesium Homeostasis

Hypercalcemia. Brian Rose, M.D. Bozeman Health June 6, 2018

Southern Derbyshire Shared Care Pathology Guidelines. Hypocalcaemia in Adults

Vitamin D: Vitamin D deficiency: 7/6/2010

Brunel Health Core Ten Results for Sam Witter. Thank you for submitting a sample of your blood to be tested by Brunel Health.

1. Adults; a. Risk factors. b. Who should be tested for vitamin D deficiency? c. Investigations. d. Who do we treat and how do we treat? 2.

Approach to a patient with hypercalcemia

Calcium and Parathyroid Disorders

Southern Derbyshire Shared Care Pathology Guidelines. Primary Hyperparathyroidism

BARTS ENDOCRINE E-PROTOCOLS CALCIUM DISORDERS AND BONE

ROTUNDA HOSPITAL DEPARTMENT OF LABORATORY MEDICINE

Hypocalcemia 6/8/12. Normal value. Physiologic functions. Nephron a functional unit of kidney. Influencing factors in Calcium and Phosphate Balance

Symptom management: Hypercalcemia

Endocrinology Update. Dr Colin Johnston Hon Consultant West Herts Trust

LRI Children s Hospital

WHAT IS YOUR DIAGNOSIS?

Magnesium Homeostasis

CKD: Bone Mineral Metabolism. Peter Birks, Nephrology Fellow

Aromatase Inhibitors & Osteoporosis

PARATHYROID, VITAMIN D AND BONE

VITAMIND. Frequently asked questions about Vitamin D in childhood

S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women

CASE PRESENTATION. Kārlis Rācenis MD - Latvia

Calcium metabolism and the Parathyroid Glands. Calcium, osteoclasts and osteoblasts-essential to understand the function of parathyroid glands

Product: Cinacalcet HCl Observational Research Clinical Study Report: Date: 23 July 2012 Page Page 2 2 of of 1203

Disorders of calcium homeostasis. FRACP part 1 lecture 2012 Peter Simm

Ca, Mg metabolism, bone diseases. Tamás Kőszegi Pécs University, Department of Laboratory Medicine Pécs, Hungary

VITAMIN D DEFICIENCY IN CHILDREN AND ADULTS: TREATMENT AND PROPHYLAXIS GUIDELINE

ESPEN Congress Prague 2007

Hypercalcemia may be detected incidentally. Practice CMAJ. Primary hyperparathyroidism. Primer. Key points. The case. What causes hypercalcemia?

Breakout Session C: Harmonisation of the Alert Table.

What this study adds: - Sustained hypercalacemia affects 1 in 500 children in a general hospital setting

Guideline for the Diagnosis and Management of Vitamin D Deficiency

Disclosure. Topic Outline. Calcium, Vitamin D, PTH Disorders. PTH/Calcium-Normal Physiology. I have nothing to disclose

Dr Seeta Durvasula.

Vitamin D Hormone Du Jour

CLINICAL GUIDELINES ID TAG

Ca, Phos and Vitamin D Metabolism in Pre-Dialysis Patients

CORNWALL & IoS GUIDELINE FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY& INSUFFICIENCY IN ADULTS

Vitamin D Deficiency. Micol Rothman, MD Assistant Professor of Medicine Clinical Director Metabolic Bone Program University of CO-Denver

HYPERCALCAEMIA 101 FOR THE INTERNIST

qthis medicinal product is subject to additional monitoring. This will allow quick identification of new safety

Hyperparathyroidism. When to Suspect, How to Diagnose, When and How to Intervene. Johanna A. Pallotta, MD, FACP, FACE

Osteoporosis challenges

CHAPTER 18 - CALCIUM CALCIUM HOMEOSTASIS

Dubai Standards of Care 2017 (Management of Vitamin D Deficiency in Children and Adults)

Shon E. Meek, M.D., Ph.D. Assistant Professor of Medicine

Oxford Kidney Unit What do my blood and dialysis results mean? Information for patients

Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

Hypercalcemia & Parathyroid Disorders. W. Reid Litchfield, MD, FACE, ECNU Desert Endocrinology

Normal Bone Health and Bone Disease. Mr Ryan Trickett Consultant Hand and Wrist Surgeon 6 th February 2017

Draft Laboratory Testing for Vitamin D Deficiency Version 4.0

ESCA: Cinacalcet (Mimpara )

Potential conflicts of interest: None

PRIMARY HYPERPARATHYROIDISM

hypercalcemia of malignancy hyperparathyroidism PHPT the most common cause of hypercalcemia in the outpatient setting the second most common cause

Bone Health in Celiac Disease. Partha S. Sinha MD, PhD October 29 th, 2017

Pathway from Fracture or Risk Factor to Treatment

Vitamin D Deficiency

REFERRAL GUIDELINES ENDOCRINOLOGY

Case Reports. A Rare Cause of Symptomatic Neonatal Hypocalcaemia EKC YAU, AWF CHENG, SY LEE, CB CHOW. Abstract. Key words.

David Bruyette, DVM, DACVIM

Hypercalcaemia with undetectable parathormone levels

OSTEOMALACIA UPDATE. Nothing to Disclose. Daniel D Bikle, MD, PhD Professor of Medicine University of California and VA Medical Center San Francisco

GUIDELINES FOR THE MANAGEMENT OF VITAMIN D DEFICIENCY

Contents. Authors Name: Christopher Wong: Consultant Nephrologist Anne Waddington: Renal Pharmacist Eimear Fegan : Renal Dietitian

Inpatient Pediatric Endocrinology. Tala Dajani MD MPH Pediatric Endocrinology of Phoenix

CONCORD INTERNAL MEDICINE VITAMIN D/CALCIUM/MAGNESIUM PROTOCOL. Revised April 8, 2012

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

VITAMIN D GUIDANCE ON MEASUREMENT OF 25-HYDROXYVITAMIN D

The Role of the Laboratory in Metabolic Bone Disease

Woman, 66, With Persistent Abdominal and Back Pain

Eastern Paediatric Epilepsy Network

SUMMARY OF THE PRODUCT CHARACTERISTICS

A Case of Severe Hypomagnesemia with Long-term Use of a Proton Pump Inhibitor

Hypercalcemia. Hypercalcemia: When to Worry, When to Treat! Mineral Metabolism : A Short Course

Dosage in renal impairment Kalcipos-D chewable tablets should not be used in patients with severe renal impairment.

SUMMARY OF PRODUCT CHARACTERISTICS

Persistent post transplant hyperparathyroidism. Shiva Seyrafian IUMS-97/10/18-8/1/2019

Lecture 4 Calcium & Phosphate Disorders Loh. Calcium distribution

Agents that Affect Bone & Mineral Homeostasis

Chronic Kidney Disease Mineral Bone Disorder (CKD-MBD)

15/9/2017 4:21:00PM 15/9/2017 4:29:07PM 19/9/2017 7:27:01PM A/c Status. Test Name Results Units Bio. Ref. Interval Bilirubin Direct 0.

DENOSUMAB SHARED CARE GUIDLINES

Osteoporosis/Fracture Prevention Clinician Guide SEPTEMBER 2017

Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO

Acute renal failure and unknown cause hypercalcemia (case report)

The Parathyroid Glands

The Parathyroid Glands Secrete Parathyroid Hormone, which Regulates Calcium, Magnesium, and Phosphate Ion Levels

What is the right calcium balance?

SUMMARY OF THE PRODUCT CHARACTERISTICS

Interpreting Blood Tests Part 1. Dr Andrew Smith

Hellenic Endocrine Society position statement: Clinical management of Vitamin D Deficiency. Spyridon Karras MD, Phd Endocrinologist

NHS LINCOLNSHIRE in association with UNITED LINCOLNSHIRE HOSPITALS TRUST

Transcription:

Clinical biochemistry of calcium and vitamin D Dr Andrew Day Consultant in Clinical Biochemistry and Metabolic Medicine University Hospitals Bristol NHS Trust e-mail: andrew.day@uhbristol.nhs.uk

A 48-year old man had progressively worsening constipation and tiredness DEPARTMENT OF CLINICAL BIOCHEMISTRY Calcium 2.68 mmol/l 2.20 2.60 Calcium (adjusted) 2.78 mmol/l 2.20 2.60 Albumin 36 g/l 35 50 Creatinine 86 μmol/l 64 104 egfr >60 ml/min/1.73 m 2 2.5 7.8 Urea 5.4 mmol/l 2.5 7.8 Sodium 142 mmol/l 133 146 Potassium 4.5 mmol/l 3.5 5.3 The two commonest causes of hypercalcaemia are..?

Causes of hypercalcaemia Primary Hyperparathyroidism Commonest in the community Often mild and stable Malignancy Humoral effect (PTHrP) Metastatic bone disease Myeloma 90% Less common causes Tertiary hyperparathyroidism in CKD Granulomatous diseases (e.g. sarcoidosis) Vitamin D toxicity (high dose, rare) Severe thyrotoxicosis Addison disease Milk alkali syndrome Familial hypocalciuric hypercalcaemia

Next investigation? PTH EDTA sample (plus SST for Ca, PO4 and creatinine) Ideally reach lab within 4 hours

Diagnosis? DEPARTMENT OF CLINICAL BIOCHEMISTRY Parathyroid hormone 8.2 pmol/l 1.6 6.9 Calcium 2.58 mmol/l 2.20 2.60 Calcium (adjusted) 2.68 mmol/l 2.20 2.60 Albumin 36 g/l 35 50 Phosphate 0.72 mmol/l 0.8 1.5 Creatinine 86 μmol/l 64 104 Primary hyperparathyroidism (but send 24-hour urine and blood sample for calculation of calcium:creatinine clearance ratio, to exclude FBHH)

Diagnosis? DEPARTMENT OF CLINICAL BIOCHEMISTRY Parathyroid hormone 4.2 pmol/l 1.6 6.9 Calcium 2.58 mmol/l 2.20 2.60 Calcium (adjusted) 2.68 mmol/l 2.20 2.60 Albumin 36 g/l 35 50 Phosphate 0.72 mmol/l 0.8 1.5 Creatinine 86 μmol/l 64 104 Still consistent with primary hyperparathyroidism (PTH inappropriately normal )

Diagnosis? DEPARTMENT OF CLINICAL BIOCHEMISTRY Parathyroid hormone <0.6 pmol/l 1.6 6.9 Calcium 2.58 mmol/l 2.20 2.60 Calcium (adjusted) 2.68 mmol/l 2.20 2.60 Albumin 36 g/l 35 50 Phosphate 0.72 mmol/l 0.8 1.5 Creatinine 86 μmol/l 64 104 Primary hyperparathyroidism excluded. Investigate other causes

Next investigations? DEPARTMENT OF CLINICAL BIOCHEMISTRY TSH 1.2 miu/l 0.27 4.2 25-OH vitamin D 68 nmol/l Serum protein electrophoresis Urine Bence Jones protein Normal pattern Negative Most likely differential diagnoses malignancy or sarcoidosis

A 45-year old woman with worsening Crohn s disease developed paraesthesiae, carpopedal spasm and had a seizure DEPARTMENT OF CLINICAL BIOCHEMISTRY Calcium 1.50 mmol/l 2.20 2.60 Calcium (adjusted) 1.80 mmol/l 2.20 2.60 Albumin 25 g/l 35-50

Why adjust a calcium result? Only ionised calcium is active and regulated How can we meaningfully measure active calcium? Measure free ionised calcium? Usually impossible Change reference range as albumin falls? Hopelessly impractical Adjust calcium to take account for low albumin Pragmatic solution Ca adj. = Ca tot. + 0.02(40-albumin)

Actions of PTH Net effect: Calcium Phosphate N.B. PTH requires Mg 2+ for secretion and action

Actions of Vitamin D Net effect: Calcium Phosphate N.B. Impaired vitamin D hydroxylation in CKD

Causes of hypocalcaemia ARTEFACTUAL HYPOCALCAEMIA Low albumin Unsuitable sample Citrate/EDTA tube HYPOPARATHYROIDISM Parathyroid loss Surgery Autoimmune Agenesis Reduced function Hypomagnasaemia Cinacalcet Neonatal PTH resistance Hypomagnasaemia REDUCED CALCIUM AVAILABILITY Vitamin D deficiency Poor diet Malabsorption Lack of sunlight Chronic kidney disease Drugs Bone resorption inhibitors Bisphosphonates Denusomab Proton pump inhibitors Increased vitamin D metabolism Phenytoin

Causes of hypocalcaemia LOW IONISED CALCIUM Hyperventilation CALCIUM CHELATION Acute pancreatitis Rhabdomyolysis Massive tumour lysis Large blood transfusions

Why does hyperventilation cause symptomatic hypocalcaemia?

Investigation of hypocalcaemia (adjusted calcium <2.20 mmol/l) Clinical assessment Risk of vitamin D deficiency Magnesium deficiency CKD Post-surgical hypoparathyroidism Other biochemistry tests Phosphate Magnesium Creatinine and egfr PTH Vitamin D PO4 & PTH Vit D deficiency Drugs e.g. bisphosphonates PO4 & PTH Hypomagnasaemia Hypoparathyroidism Drugs e.g. cinacalcet PO4 & PTH CKD Tumour lysis Rhabdomyolysis Acute pancreatitis

A 45-year old woman with worsening Crohn s disease developed paraesthesiae, carpopedal spasm and had a seizure DEPARTMENT OF CHEMICAL PATHOLOGY Calcium 1.50 mmol/l 2.20 2.60 Calcium (adjusted 1.80 nmol/l 2.20 2.60 Albumin 25 g/l 35-50 Phosphate 0.69 mmol/l 0.80 1.50 Magnesium 0.42 nmol/l 0.70 1.00 25-hydroxyvitamin D 8 nmol/l Sufficient >50 Parathyroid hormone 12.8 pmol/l 1.6 6.9

Testing for Vitamin D

Vitamin D metabolism

A 42-year old Somalian woman attends for a well-woman check DEPARTMENT OF CHEMICAL PATHOLOGY Total 25-hydroxy Vitamin D 20.3 nmol/l (25-hydroxy Vitamin D2) <6.0 nmol/l (25-hydroxy Vitamin D3) 20.3 nmol/l <30 nmol/l 30 50 nmol/l >50 nmol/l Vitamin D deficiency Vitamin D may be suboptimal Sufficient vitamin D This assay does NOT detect 1α-hydroxycholecalciferol

Regarding vitamin D WHICH OF THE FOLLOWING STATEMENTS ABOUT VITAMIN D ARE CORRECT? 1 Each test costs approximately 10 2 Testing is now recommended in all groups who are at risk of deficiency 3 Testing is important prior to treatment with daily doses above 400 IU because of risk of toxicity 4 Testing is recommended in people with unexplained myalgia or widespread pain 5 Monitoring during therapy is recommended only in patients with malabsorption, ongoing symptoms or suspected poor compliance

Regarding vitamin D WHICH OF THE FOLLOWING STATEMENTS ABOUT VITAMIN D ARE CORRECT? 1 Each test costs approximately 10 2 Testing is now recommended in all groups who are at risk of deficiency 3 Testing is important prior to treatment with daily doses above 400 IU because of risk of toxicity 4 Testing is recommended in people with unexplained myalgia or widespread pain 5 Monitoring during therapy is recommended only in patients with malabsorption, ongoing symptoms or suspected poor compliance

National Osteoporosis Society May 2013 (http://www.osteoporosis-resources.org.uk/)

Most people don t need a vitamin D test

Most people don t need a vitamin D test

Most people don t need a vitamin D test Most adults get enough from sunlight in spring / summer 10 mcg in autumn and winter Little or no sun exposure, or dark skin 10 mcg all year round Children age 1 4 10 mcg all year round Breastfed babies up to 1 0.85 10 mcg daily

Who should have a vitamin D test? Confirmed osteomalacia Prior to treatment of osteoporosis with potent anti-resorptive Rx Zoledronate Denosumab Other bone diseases (e.g. Paget s) before starting bisphosphonate

Who should have a vitamin D test? Patients with symptoms that could be attributed to vitamin D deficiency Suspected osteomalacia Chronic widespread bone pain Proximal muscle weakness Waddling gait or change in gait

Who should have a vitamin D test? Other specific indications for vitamin D testing Malabsorption Newly diagnosed primary hyperparathyroidism Unexplained hypocalcaemia Sup. If <50 nmol/l and recheck [Ca] within 2/52? Pre-treatment vitamin D <30 nmol/l Concerns re. poor compliance

Who should have a vitamin D test? Asymptomatic individuals at high risk of vitamin D deficiency Do not routinely test vit D in these groups

Who should have a vitamin D test? Although vitamin D deficiency is highly prevalent, universal screening of asymptomatic populations is not recommended

Risk Factors? Symptoms? Treat Investigate Vitamin D Calcium and phosphate LFT U&E? PTH

Vit D <30 Vit D 30-50 Vit D >50 Loading dose 300,000 U Information and advice Supplement 800 U/day Retesting is not routinely indicated